content: <p align="center"><font face="Times New Roman, Times, serif" size="5"><b>UNITED STATES<br>
  SECURITIES AND EXCHANGE COMMISSION</b></font><b><font face="Times New Roman, Times, serif" size="2"><br>
  Washington, D.C.&nbsp;&nbsp;20549</font></b></p><p align="center"><b><font face="Times New Roman, Times, serif" size="2"> <font size="5">FORM
  8-K/A</font></font></b></p><p align="center"><b><font face="Times New Roman, Times, serif" size="3">(Amendment No. 1)<br>
  CURRENT REPORT</font></b></p><p align="center"><b><font face="Times New Roman, Times, serif" size="3"><br>
  </font></b><font face="Times New Roman, Times, serif" size="3"><b>Pursuant to
  Section 13 OR 15(d) of The Securities Exchange Act of 1934</b></font></p><p><font face="Times New Roman, Times, serif" size="2"><br>
  Date of Report (Date of earliest event reported)&nbsp;&nbsp;<b><u>May 12, 2010</u></b><br>
  </font></p><div align="center"><b><font size="6" face="Arial, Helvetica, sans-serif"><img src="nve-logo.gif" width="276" height="55"><br>
  NVE Corporation</font></b><font face="Times New Roman, Times, serif" size="2"><br>
  (Exact name of registrant as specified in its charter)</font></div><font face="Times New Roman, Times, serif" size="2">
  <div align="center">
  <p>&nbsp;</p></div></font>
  <div align="center"></div><table border="0" cellspacing="0" cellpadding="0" width="100%">
  <tr>
  <td width="33%">
  <p align="center"><font face="Times New Roman, Times, serif"><b><font size="2" ><u>Minnesota</u></font></b></font></p></td><td width="33%">
  <div align="center"><font face="Times New Roman, Times, serif" size="2"><b><u>000-12196</u>
  </b></font></div></td><td>
  <p align="center"><b><font size="2" face="Times New Roman"><u>41-1424202</u></font></b></p></td></tr>
  <tr>
  <td>
  <p align="center"><font size="2" face="Times New Roman, Times, serif">(State
  or other jurisdiction of incorporation)</font></p></td><td>
  <div align="center"><font face="Times New Roman, Times, serif" size="2">(Commission File Number) </font></div></td><td>
  <div align="center"><font size="2" face="Times New Roman, Times, serif">(IRS Employer Identification No.)</font></div></td></tr>
  </table><br>
  <br>
  <table border="0" cellspacing="0" cellpadding="0" width="100%">
  <tr>
  <td rowspan="2" width="25%"></td><td width="50%">
  <p align="center"><font size="2"><b><u>11409 Valley View Road, Eden Prairie,
  Minnesota</u></b></font></p></td><td>
  <p align="center"><font size="2"><b><font face="Times New Roman" ><u>55344</u></font></b></font></p></td></tr>
  <tr>
  <td width="50%">
  <p align="center"><font size="2" face="Times New Roman, Times, serif">(Address
  of principal executive offices)</font></p></td><td>
  <p align="center"><font size="2">(Zip Code)</font></p></td></tr>
  </table><br>
  <font size="2" face="Times New Roman, Times, serif"> Registrant&#146;s telephone
  number, including area code <b><u>(952) 829-9217</u></b><br>
  </font>
  <p align="center"><font face="Times New Roman, Times, serif" size="2"><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><br>
  (Former name or former address, if changed since last report.)</font></p><p><font face="Times New Roman, Times, serif" size="2">Check the appropriate box
  below if the Form 8-K filing is intended to simultaneously satisfy the filing
  obligation of the registrant under any of the following provisions (see General
  Instruction A.2. below):<br>
  <br>
  [&nbsp;&nbsp;] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)<br>
  <br>
  [&nbsp;&nbsp;] Soliciting material pursuant to Rule 14a-12 under the Exchange
  Act (17 CFR 240.14a-12)<br>
  <br>
  [&nbsp;&nbsp;] Pre-commencement communications pursuant to Rule 14d-2(b) under
  the Exchange Act (17 CFR 240.14d-2(b))<br>
  <br>
  [&nbsp;&nbsp;] Pre-commencement communications pursuant to Rule 13e-4(c) under
  the Exchange Act (17 CFR 240.13e-4(c))<br><br>
  </font>
  <hr><br clear="all" style="page-break-before:always;">
  <font face="Times New Roman, Times, serif" size="2"><b>Explanatory Note</b><br>
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This Amendment Number 1 to Form 8-K is being filed to disclose a letter of intent relating to a Supply Agreement by and between NVE Corporation and Phonak AG.<br><br><br>
  <b>Item 1.01 Entry into a Material Definitive Agreement</b><br>
  <br>
  <b><i>General information</i></b><br>
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Phonak AG develops, manufactures, and sells hearing systems using our spintronic  sensors under the Supply Agreement.<br>
  <br>
  <b><i>Description of the Terms of the Agreement</i></b>
  <br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On May&nbsp;12, 2010 we executed a letter of intent relating to the Supply Agreement.
  The Letter of Intent sets immediate pricing and defines the terms for an amendment to the Supply Agreement
  including an extension of the Supply Agreement term through March 31, 2015, an expansion of NVE products under
  the scope of the Supply Agreement, minimum purchase requirements, and pricing provisions.
  <br>
  <p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><div align="center">2</div></font>
  <hr><br clear="all" style="page-break-before:always;">
  <font face="Times New Roman, Times, serif" size="2">
  <div align="center"><b>SIGNATURE</b><br>
  <br>
  </div>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant
  to the requirements of the Securities Exchange Act of 1934, the registrant has
  duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.<br>
  &nbsp;
  </font>
  <table border="0" cellspacing="0" cellpadding="0" width="100%">
  <tr>
  <td width="33%" valign="top">
  <font face="Times New Roman, Times, serif" size="2">Date&nbsp;&nbsp;<b><u>May&nbsp;12,&nbsp;2010</u></b>
  </font>
  </td><td align="center" width="34%"><font face="Times New Roman, Times, serif" size="2"><b><u>NVE CORPORATION<br>
  </u></b>(Registrant)<br>
  &nbsp;<br>
  <u>/s/ DANIEL A. BAKER</u><br>Daniel A. Baker<br>President and<br>
  Chief Executive Officer</font></td><td width="33%"></td></tr>
  </table><p>
  <p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p align="center"><font face="Times New Roman, Times, serif" size="2">3</font>
  <hr><br clear="all" style="page-break-before:always;">
  <div align="center"><font face="Times New Roman, Times, serif" size="2"><b>INDEX TO EXHIBITS</b><br>
  <br>
  </font></div><table width="100%" border="0" cellspacing="0" cellpadding="0">
  <tr>
  <td width="1%">
  <div align="center"><font face="Times New Roman, Times, serif" size="2"><b><u>Exhibit&nbsp;#</u></b></font></div></td><td width="88%">
  <div align="center"><font face="Times New Roman, Times, serif" size="2"><b><u>Description</u></b></font></div></td></tr>
  <tr>
  <td colspan="2"><font face="Times New Roman, Times, serif" size="2">&nbsp;</font></td></tr><tr><td valign="top"><font face="Times New Roman, Times, serif" size="2">&nbsp;&nbsp;10.1</font></td><td align="center"><font face="Times New Roman, Times, serif" size="2">Supply Agreement by and between the company and Phonak AG (incorporated by reference to our Current Report on Form 8-K filed May 6, 2009).<br>&nbsp;</font></td></tr>
  <tr>
  <td valign="top">
  <font face="Times New Roman, Times, serif" size="2">&nbsp;&nbsp;10.2+</font></td><td align="center"><font face="Times New Roman, Times, serif" size="2">Letter of Intent relating to Supply Agreement by and between NVE Corporation and Phonak AG.</font></td></tr>
  </table><p><font face="Times New Roman, Times, serif" size="2">+Confidential portions of this exhibit were deleted and filed separately with the SEC under a request for confidential treatment pursuant to Rule 24b-2 or Rule 406.<div align="center"><br><br><br><br><br><br><br><br><br><br>
  4</div></font>
  <hr>
metadata_documents: [{"type": "8-K", "sequence": "1", "filename": "phonak8k.htm", "description": "AMENDMENT NO. 1 TO CURRENT REPORT ON FORM 8-K", "secsgml_size_bytes": 8279}]
metadata_filer: {"company-data": {"conformed-name": "NVE CORP /NEW/", "cik": "0000724910", "assigned-sic": "3674", "irs-number": "411424202", "state-of-incorporation": "MN", "fiscal-year-end": "0331"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-12196", "film-number": "10824566"}, "business-address": {"street1": "11409 VALLEY VIEW ROAD", "city": "EDEN PRAIRIE", "state": "MN", "zip": "55344", "phone": "9528299217"}, "mail-address": {"street1": "11409 VALLEY VIEW ROAD", "city": "EDEN PRAIRIE", "state": "MN", "zip": "55344"}, "former-company": {"former-conformed-name": "PREMIS CORP", "date-changed": "19920703"}}
text: UNITED STATES
  SECURITIES AND EXCHANGE COMMISSION
  Washington, D.C.  20549
  FORM
  8-K/A
  (Amendment No. 1)
  CURRENT REPORT
  Pursuant to
  Section 13 OR 15(d) of The Securities Exchange Act of 1934
  Date of Report (Date of earliest event reported)
  May 12, 2010
  NVE Corporation
  (Exact name of registrant as specified in its charter)
  Minnesota
  000-12196
  41-1424202
  (State
  or other jurisdiction of incorporation)
  (Commission File Number)
  (IRS Employer Identification No.)
  11409 Valley View Road, Eden Prairie,
  Minnesota
  55344
  (Address
  of principal executive offices)
  (Zip Code)
  Registrant's telephone
  number, including area code
  (952) 829-9217
  (Former name or former address, if changed since last report.)
  Check the appropriate box
  below if the Form 8-K filing is intended to simultaneously satisfy the filing
  obligation of the registrant under any of the following provisions (see General
  Instruction A.2. below):
  [  ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
  [  ] Soliciting material pursuant to Rule 14a-12 under the Exchange
  Act (17 CFR 240.14a-12)
  [  ] Pre-commencement communications pursuant to Rule 14d-2(b) under
  the Exchange Act (17 CFR 240.14d-2(b))
  [  ] Pre-commencement communications pursuant to Rule 13e-4(c) under
  the Exchange Act (17 CFR 240.13e-4(c))
  Explanatory Note
  This Amendment Number 1 to Form 8-K is being filed to disclose a letter of intent relating to a Supply Agreement by and between NVE Corporation and Phonak AG.
  Item 1.01 Entry into a Material Definitive Agreement
  General information
  Phonak AG develops, manufactures, and sells hearing systems using our spintronic  sensors under the Supply Agreement.
  Description of the Terms of the Agreement
  On May 12, 2010 we executed a letter of intent relating to the Supply Agreement.
  The Letter of Intent sets immediate pricing and defines the terms for an amendment to the Supply Agreement
  including an extension of the Supply Agreement term through March 31, 2015, an expansion of NVE products under
  the scope of the Supply Agreement, minimum purchase requirements, and pricing provisions.
  2
  SIGNATURE
  Pursuant
  to the requirements of the Securities Exchange Act of 1934, the registrant has
  duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
  Date
  May 12, 2010
  NVE CORPORATION
  (Registrant)
  /s/ DANIEL A. BAKER
  Daniel A. Baker
  President and
  Chief Executive Officer
  3
  INDEX TO EXHIBITS
  Exhibit #
  Description
  10.1
  Supply Agreement by and between the company and Phonak AG (incorporated by reference to our Current Report on Form 8-K filed May 6, 2009).
  10.2+
  Letter of Intent relating to Supply Agreement by and between NVE Corporation and Phonak AG.
  +Confidential portions of this exhibit were deleted and filed separately with the SEC under a request for confidential treatment pursuant to Rule 24b-2 or Rule 406.
  4